All fields · Hepatology

JournalQ1· SCImago 2025

Cancers

ISSN 2072-6694

• Q1Quartile
• 1.00SJR
• 182h-index
• 24papers summarised

About this journal

Cancers is a Q1 journal by SCImago Journal Rank (2025 data), with an SJR of 1.00 and an h-index of 182. Most of its papers in the Pofolia pool fall under Hepatology. Pofolia holds AI summaries of 24 paper(s) from this journal; the most cited is “Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment” (634 citations).

The quartile (Q1–Q4) is the journal's percentile position within its subject area by SCImago Journal Rank; Q1 is the top 25%. What is a Q1 journal? · What is the h-index?

Most-cited papers in Hepatology →

Papers we summarise from this journal

• Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment2018 · 634 citations
• Update on Prevalence of Pain in Patients with Cancer 2022: A Systematic Literature Review and Meta-Analysis2023 · 389 citations
• A Contemporary Review of Resectability and Treatment Strategies for Colorectal Liver Metastases: Part 1—Diagnosis, Defining Resectability, and Management of Upfront Resectable and Synchronous Disease2026 · 1 citations
• Do Glioblastoma Cancer Cells Need Vitamins? The Role of Vitamin B12026 · 0 citations
• Optimized Feature Engineering and Machine Learning Approaches for Early Prediction of Renal Cell Carcinoma2026 · 0 citations
• Urinary Biomarkers in Cancer: A Scoping Review2026 · 0 citations
• Liver Transplantation for Fibrolamellar Carcinoma: National Registry Analysis and Reported Outcomes2026 · 0 citations
• Ki-67 Proliferation Index Improves the Prognostic Stratification Accuracy of International Staging System in Newly Diagnosed Multiple Myeloma2026 · 0 citations
• Baseline D-Dimer Predicts Subsequent Venous Thromboembolism in 23,505 Patients with One of 11 Solid Malignancies: An 11-Year Retrospective Cohort Study2026 · 0 citations
• Management Strategies for Cutaneous Adverse Events Caused by Kinase Inhibitors in Oncology: A Systematic Review and Meta-Analysis2026 · 0 citations
• Choosing Between Anti-TROP2 ADCs in Advanced Breast Cancer Without Head-to-Head Evidence: A Practical Evidence-Informed Decision Framework Endorsed by the Polish Society of Clinical Oncology2026 · 0 citations
• Distinct Expression Patterns of miR-21-5p and miR-21-3p in Oral Epithelial Dysplasia and Early Oral Squamous Cell Carcinoma2026 · 0 citations
• Urine Drug Testing at an Ambulatory Pain Clinic in Patients Receiving Opioids for Cancer Pain2026 · 0 citations
• Diagnostic Accuracy of Amino Acid PET for Differentiating Tumor Recurrence or Progression from Treatment-Related Changes in Glioma Patients: A Uppstematic Review and Meta-Analysis2026 · 0 citations
• Treatment-Free Interval as a Prognostic Factor for Survival Outcomes in Patients with Advanced or Recurrent Endometrial Cancer Treated with Pembrolizumab Plus Lenvatinib: A Multi-Institutional Real-World Cohort Study2026 · 0 citations
• Multi-Scale MRI, Radiology Reports, and Blood Biomarker–Guided Multimodal Deep Learning for Predicting Postoperative Recurrence in Cervical Cancer: A Multicenter Study2026 · 0 citations
• A Dual-Ligand PDC Co-Targeting FOLR1 and c-Met Enhances Tumor Accumulation and Antitumor Efficacy in Ovarian Cancer2026 · 0 citations
• Non-Invasive Skin Imaging Techniques for Diagnosing and Monitoring Mycosis Fungoides: A Comprehensive Review2026 · 0 citations
• Altered Lipolytic Protein Expression in Tumor-Associated Adipose Tissue Correlates with Aggressive Breast Cancer Features2026 · 0 citations
• Disappearing Colorectal Liver Metastases: Should the Treatment Sequence Be Reconsidered for Selected Lesions?2026 · 0 citations
• ELN vs. IPSS-M in MDS/AML: Which Prognostic System Should Guide Clinical Decision-Making?2026 · 0 citations
• PET|MR Open Source Radiomics Models for Treatment Outcome Prediction in Recurrent GBM2026 · 0 citations
• Fertility-Sparing Treatment of Endometrial Cancer and Atypical Endometrial Hyperplasia by Molecular Classification: A Systematic Review and Meta-Analysis Accounting for Outcome-Assessment Timing and Follow-Up Duration2026 · 0 citations
• Increasing H3K9 Methylation Level Reduces the Proliferation of Leukemic Stem Cells2026 · 0 citations

Journals in the same field

See every journal in the field →